Published in J Invest Dermatol on October 01, 1991
The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta (2010) 3.33
Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal (2008) 2.97
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest (1998) 1.95
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene (2000) 1.77
Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest (1992) 1.45
Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J Clin Invest (1999) 1.14
Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci U S A (1992) 1.11
Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: potential therapeutic application for treatment of gliomas. Neuro Oncol (2008) 1.08
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer (1995) 1.07
Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival. Biochem J (2003) 1.07
Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Br J Cancer (2001) 1.03
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer (1996) 1.00
Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease. Respir Physiol Neurobiol (2010) 0.92
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax (1999) 0.90
Cannabidiol inhibits angiogenesis by multiple mechanisms. Br J Pharmacol (2012) 0.89
Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics. Arthritis Res (2002) 0.87
A novel mechanism of matrix metalloproteinase-9 gene expression implies a role for keratinization. EMBO Rep (2001) 0.85
Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study. BMC Neurosci (2005) 0.85
Ovarian expression, localization, and function of tissue inhibitor of metalloproteinase 3 (TIMP3) during the periovulatory period of the human menstrual cycle. Biol Reprod (2013) 0.80
A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma. Am J Pathol (2001) 0.80
The effect of TIMP-1 on the cone mosaic in the retina of the rat model of retinitis pigmentosa. Invest Ophthalmol Vis Sci (2014) 0.79
Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid. Graefes Arch Clin Exp Ophthalmol (2011) 0.79
Changes in gene expression associated with matrix turnover, chondrocyte proliferation and hypertrophy in the bovine growth plate. Acta Naturae (2014) 0.78
Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants. Am J Physiol Lung Cell Mol Physiol (2015) 0.77
Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression. Int J Med Sci (2017) 0.75
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer. BMC Cancer (2010) 0.75
Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury. BMC Nephrol (2016) 0.75
An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells. PLoS One (2016) 0.75
Neurogenic differentiation factor NeuroD confers protection against radiation-induced intestinal injury in mice. Sci Rep (2016) 0.75
SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem (1989) 5.64
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem (1988) 4.06
Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem (1986) 3.67
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol (2007) 2.85
Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest (1990) 2.56
Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry (1977) 2.39
The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem (1981) 2.26
Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A (1989) 2.26
Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A (1989) 2.12
Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun (1975) 2.12
Human skin collagenase. Isolation and mechanism of attack on the collagen molecule. Biochim Biophys Acta (1968) 2.05
Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A (1987) 1.89
The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol (2001) 1.79
Chronic radiodermatitis following cardiac catheterisation: a report of two cases and a brief review of the literature. Heart (1999) 1.78
The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products. J Biol Chem (1987) 1.78
Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77
Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest (1979) 1.73
Connective tissue nevi of the skin. Clinical, genetic, and histopathologic classification of hamartomas of the collagen, elastin, and proteoglycan type. J Am Acad Dermatol (1980) 1.71
Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell (1991) 1.65
Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol (1996) 1.58
Cutaneous mycobacteriosis: analysis of 34 cases with a new classification of the disease. Medicine (Baltimore) (1981) 1.57
Neutrophilic dermatoses during granulocytopenia. Arch Dermatol (1995) 1.56
Human skin collagenase: relationship to the pathogenesis of epidermolysis bullosa dystrophica. J Invest Dermatol (1969) 1.54
Inhibition of human skin collagenase by human serum. J Lab Clin Med (1970) 1.53
A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol (2002) 1.52
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
The reconstitution of living skin. J Invest Dermatol (1983) 1.49
[Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients]. Ann Dermatol Venereol (2003) 1.47
Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry (1978) 1.47
Evidence of a marked 25-hydroxyvitamin D deficiency in patients with congenital ichthyosis. J Eur Acad Dermatol Venereol (2006) 1.45
Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. J Invest Dermatol (1991) 1.44
Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis. Proc Natl Acad Sci U S A (1986) 1.44
Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol (1997) 1.43
Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection. J Am Acad Dermatol (1992) 1.43
[Thalidomide and thrombosis]. Ann Dermatol Venereol (2000) 1.40
Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry (1983) 1.39
Enzyme-linked immunosorbent assay for human skin collagenase. Coll Relat Res (1983) 1.38
Acral persistent papular mucinosis and IgA monoclonal gammopathy: report of a case. Dermatology (1992) 1.38
A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem (1979) 1.37
Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll Relat Res (1985) 1.37
Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol (1977) 1.33
Human skin collagenase. The role of serum alpha-globulins in the control of activity in vivo and in vitro. Proc Natl Acad Sci U S A (1971) 1.31
Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J Clin Invest (1992) 1.29
Human skin collagenase: localization and distribution in normal human skin. J Invest Dermatol (1969) 1.28
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28
Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem (2000) 1.26
Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. Anal Biochem (1998) 1.21
Autosomal recessive lamellar ichthyosis: identification of a new mutation in transglutaminase 1 and evidence for genetic heterogeneity. Hum Mol Genet (1995) 1.20
Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science (1985) 1.18
Human skin fibroblast collagenase. Assessment of activation energy and deuterium isotope effect with collagenous substrates. J Biol Chem (1981) 1.17
Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci U S A (1985) 1.15
Purification and properties of a gelatin-specific neutral protease from human skin. J Biol Chem (1981) 1.15
The function of Ca+ in the action of mammalian collagenases. Arch Biochem Biophys (1976) 1.13
Mapping of Papillon-Lefevre syndrome to the chromosome 11q14 region. Eur J Hum Genet (1997) 1.13
Animal and human collagenases. J Invest Dermatol (1970) 1.12
The gelatinolytic activity of human skin fibroblast collagenase. J Biol Chem (1982) 1.12
Studies on purified rheumatoid synovial collagenase in vitro and in vivo. J Clin Invest (1971) 1.12
Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells. Eur J Biochem (1994) 1.12
The role of epithelium and mesenchyme in the production of a collagenolytic enzyme and a hyaluronidase in the anuran tadpole. Dev Biol (1965) 1.12
Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Biol Chem (1989) 1.11
Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1994) 1.10
Collagenase in human cornea: immunologic localization. Arch Ophthalmol (1980) 1.09
Properties and subcellular localization of elastase-like activities of arterial smooth muscle cells in culture. Biochim Biophys Acta (1983) 1.08
Cleavage specificity of human skin type IV collagenase (gelatinase). Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides. J Biol Chem (1990) 1.07
Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. J Invest Dermatol (1992) 1.07
Regulation of human skin collagenase activity by hydrocortisone and dexamethasone in organ culture. Biochem Biophys Res Commun (1974) 1.07
Cell survival and shuttle vector mutagenesis induced by ultraviolet A and ultraviolet B radiation in a human cell line. J Invest Dermatol (1996) 1.07
Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol (1980) 1.06
Non-coherent near infrared radiation protects normal human dermal fibroblasts from solar ultraviolet toxicity. J Invest Dermatol (1998) 1.06
A sensitive microassay for prolyl hydroxylase: activity in normal and psoriatic skin. J Invest Dermatol (1973) 1.06
Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors. J Invest Dermatol (1995) 1.05
The role of human skin collagenase in epidermolysis bullosa. J Invest Dermatol (1977) 1.05
Differentiation of a human leukemia cell line and expression of collagenase inhibitor. Proc Natl Acad Sci U S A (1985) 1.05
Immunologic relationship of a purified human skin collagenase to other human and animal collagenases. Biochim Biophys Acta (1970) 1.04
HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol (2001) 1.04
UVA-induced lipid peroxidation in cultured human fibroblasts. Biochim Biophys Acta (1991) 1.03
Studies on elastic tissue of aorta in aortic dissections and Marfan syndrome. Pathol Biol (Paris) (1981) 1.03
Radioimmunoassay of human collagenase. Specificity of the assay and quantitative determination of in vivo and in vitro human skin collagenase. J Biol Chem (1972) 1.03
Recessive dystrophic epidermolysis bullosa. Evidence for increased collagenase as a genetic characteristic in cell culture. J Exp Med (1978) 1.03
Inhibition of collagen degradative enzymes by retinoic acid in vitro. J Am Acad Dermatol (1982) 1.02
Enhanced collagenase production by fibroblasts derived from human basal cell carcinomas. Cancer Res (1979) 1.02
A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. Br J Dermatol (2007) 1.02
Verrucous lesion in patients with discoid lupus erythematosus. Clinical, histopathological and immunofluorescence studies. Br J Dermatol (1978) 1.02
Characterization of a collagenase from rat skin. Biochim Biophys Acta (1972) 1.02
Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res (1994) 1.01
The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett (1995) 1.00
Evidence for mammalian collagenases as zinc ion metalloenzymes. Biochim Biophys Acta (1977) 1.00
Influence of homocysteine on matrix metalloproteinase-2: activation and activity. Biochem Biophys Res Commun (1999) 1.00
Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators, and phorbol myristate acetate. Arteriosclerosis (1990) 1.00
Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices. Exp Cell Res (2001) 0.99
Preparation of three vertebrate collagenases in pure form. Biochem Biophys Res Commun (1971) 0.99
Physicochemical properties and stability of anthralin in model systems and human skin. J Invest Dermatol (1983) 0.99
T-cell receptor-gamma/delta bearing lymphocytes in normal and inflammatory human skin. J Invest Dermatol (1990) 0.99
Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. Br J Dermatol (2009) 0.99
Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. J Immunol (1997) 0.99
Decreased collagenase production by regional fibroblasts cultured from skin of a patient with connective tissue nevi of the collagen type. J Invest Dermatol (1982) 0.99
Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation. Biol Chem (1997) 0.99
Characteristics of the action of human skin fibroblast collagenase on fibrillar collagen. J Biol Chem (1980) 0.98
Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line. Clin Exp Metastasis (1998) 0.97